J&J, Bristol Myers lose challenges to US drug price negotiation (Credits: Accountable US) Bristol Myers Squibb has already filed an appeal, while Johnson & Johnson expressed disappointment with ...
🔍 Case Summary: The court rejected a legal challenge by Bristol Myers Squibb and Johnson & Johnson against a mandate requiring them to negotiate drug prices for their leading blood clot ...
If you’re on the fence about investing in Johnson & Johnson or Bristol-Myers Squibb Co because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...
The multiple myeloma market is booming. Bloomberg Intelligence (BI) forecasts sales will hit $33 billion in 2030, up almost ...
Bristol-Myers Squibb faces a soft growth outlook, but high expected free cash flow and steady sales suggest today's valuation is simply too low. With a dividend yield now near 6%, I outline key ...
The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and South Korea(KR) patent Office are among the top ten patent offices where Bristol-Myers Squibb is ...
Bristol-Myers and its Mead Johnson unit sued Danbury Pharmaceuticals alleging that the company had infringed its buspirone patent by requesting US Food and Drug Administration approval to market the ...
Expenses related to acquisitions recently weighed down Bristol Myers' earnings results. The company, however, still generates strong free cash flow. Its high debt load could turn off some risk ...
As of May 31, 2024, Johnson & Johnson had a $349.6 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s ...
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products ...
The company recently posted a big loss On April 25, Bristol Myers reported its most recent quarterly numbers. While its top line was decent -- the healthcare company's revenue grew by 5% year over ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...